Lv11
60 积分 2024-10-15 加入
Treatment Delays in Early Age–Onset Colorectal Cancer
1小时前
待确认
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial
2小时前
已完结
Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer
10天前
已完结
Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer
10天前
已完结
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial
18天前
已完结
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
21天前
已完结
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
1个月前
已关闭
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer
1个月前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
1个月前
已完结
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
